Table 2

Association of non-adherence and subsequent all-cause readmissions

Measure90-day adjusted* HR (95% CI)365-day adjusted* HR (95% CI)
Acute myocardial infarction
 Aspirin at arrival1.19 (0.29 to 4.86)1.07 (0.34 to 3.37)
 β blocker at arrival0.65 (0.16 to 2.69)0.35 (0.09 to 1.43)
 PCI <90 min2.36 (1.14 to 4.85)2.42 (1.40 to 4.20)
 Aspirin (D/C)2.12 (0.68 to 6.66)1.84 (0.69 to 4.95)
 β blocker (D/C)0.61 (0.15 to 2.45)0.88 (0.37 to 2.14)
 ACEI/ARB for LVSD1.20 (0.76 to 1.89)1.19 (0.82 to 1.72)
 Smoking counselling2.02 (1.13 to 3.62)1.59 (0.93 to 2.70)
Arrival group measures1.17 (0.71 to 1.92)1.05 (0.70 to 1.57)
Discharge group measures1.59 (1.16 to 2.18)1.49 (1.14 to 1.93)
Failure on any measure1.47 (1.12 to 1.93)1.32 (1.06 to 1.66)
0–49% adherence (vs all)1.97 (1.35 to 2.88)2.09 (1.53 to 2.86)
50–99% adherence (vs all)1.18 (0.82 to 1.71)0.97 (0.71 to 1.32)
Heart failure
 ACEI/ARB for LVSD1.53 (1.09 to 2.16)1.35 (1.01 to 1.79)
 LV assessment0.86 (0.44 to 1.66)1.02 (0.63 to 1.66)
 Discharge instruction*1.20 (1.006 to 1.42)1.20 (1.05 to 1.37)
 Smoking counselling0.93 (0.55 to 1.56)1.09 (0.73 to 1.63)
Patient information: none vs all1.17 (0.98 to 1.38)1.20 (1.05 to 1.36)
Failure on any measure1.07 (0.92 to 1.25)1.13 (1.00 to 1.27)
0–49% vs 100% compliance1.01 (0.85 to 1.20)1.07 (0.94 to 1.22)
50–99% vs 100% compliance1.25 (0.98 to 1.59)1.30 (1.07 to 1.57)
Pneumonia
 Antibiotic <4 h1.22 (0.94 to 1.58)1.16 (0.96 to 1.41)
 Blood culture timing1.00 (0.73 to 1.37)1.05 (0.83 to 1.32)
 O2 assessmentNANA
 Antibiotic selection1.29 (0.85 to 1.96)1.58 (1.19 to 2.10)
 Influenza vaccine assessment1.14 (0.86 to 1.52)1.11 (0.89 to 1.38)
 Pneumonia vaccine assessment1.19 (0.96 to 1.49)1.07 (0.90 to 1.27)
 Smoking counselling1.59 (1.08 to 2.34)1.38 (1.02 to 1.87)
Arrival group measure1.08 (0.88 to 1.33)1.11 (0.95 to 1.30)
Health maintenance measures1.10 (0.90 to 1.35)1.07 (0.92 to 1.25)
Failure on any measure1.16 (0.97 to 1.38)1.14 (0.99 to 1.30)
0–49% adherence (vs all)1.40 (1.11 to 1.77)1.39 (1.16 to 1.67)
50–99% adherence (vs all)1.02 (0.84 to 1.24)1.02 (0.88 to 1.19)
  • Confounders included patient's age, gender, race, socioeconomic status, comorbidities at admission, DNR order on admission for arrival measures, DNR order anytime during hospitalisation for other measures, and transfer to Massachusetts General Hospital for non-arrival measures.

  • * Discharge instruction model was restricted to patients who were discharged home.

  • ACEI/ARB, angiotensin-converting enzyme inhibitor/angiotensin receptor blockade; D/C, discharge; DNR, do not resuscitate; LV, left ventricle; LVSD, left ventricular systolic dysfunction; NA, not available.